Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
About
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistance to Famitinib and Camrelizumab”

1 trials

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 1 of 1 results

Not applicableUnknownNCT03919539

What this trial is testing

Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab

Who this might be right for

Drug Resistance to Famitinib and CamrelizumabBiomarkers for Efficacy and Toxicity

Peking University People's Hospital 40